Cargando…

Ketamine enhances structural plasticity in human dopaminergic neurons: possible relevance for treatment-resistant depression

Detalles Bibliográficos
Autores principales:	Collo, Ginetta, Merlo Pich, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950671/ https://www.ncbi.nlm.nih.gov/pubmed/29722313 http://dx.doi.org/10.4103/1673-5374.230288

Ejemplares similares

Structural Plasticity Induced by Ketamine in Human Dopaminergic Neurons as Mechanism Relevant for Treatment-Resistant Depression
por: Collo, Ginetta, et al.
Publicado: (2019)

A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: focus on dopaminergic system
por: Collo, Ginetta, et al.
Publicado: (2019)

Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons
por: Collo, Ginetta, et al.
Publicado: (2018)

Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine
por: Collo, Ginetta, et al.
Publicado: (2014)

Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
por: Collo, Ginetta, et al.
Publicado: (2020)

Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
por: Collo, Ginetta, et al.
Publicado: (2021)

Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling
por: Collo, Ginetta, et al.
Publicado: (2018)

Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic Neurons
por: Orlando, Rosamaria, et al.
Publicado: (2022)

Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine
por: Liu, Linda Xing Yu, et al.
Publicado: (2021)

Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report
por: Joseph, Boney, et al.
Publicado: (2023)

Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential
por: Fedele, Stefania, et al.
Publicado: (2017)

A new mechanism for protection of dopaminergic neurons mediated by astrocytes
por: Segura-Aguilar, Juan
Publicado: (2015)

Application of flavonoids for the protection of nigral dopaminergic neurons from oxidative stress
por: Kim, Sang Ryong
Publicado: (2020)

Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons
por: Kim, Sang Ryong
Publicado: (2014)

Modulating neuronal plasticity with choline
por: Chin, Eunice W. M., et al.
Publicado: (2019)

The inherent high vulnerability of dopaminergic neurons toward mitochondrial toxins may contribute to the etiology of Parkinson's disease
por: Wimalasena, Kandatege
Publicado: (2016)

Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons
por: Bono, Federica, et al.
Publicado: (2017)

Methylation reactions at dopaminergic nerve endings, serving as biological off-switches in managing dopaminergic functions
por: Charlton, Clivel G.
Publicado: (2014)

Patterning inconsistencies restrict the true potential of dopaminergic neurons derived from human induced pluripotent stem cells
por: Mahajani, Sameehan, et al.
Publicado: (2020)

The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020)

Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
por: Merlo Pich, Emilio, et al.
Publicado: (2014)

Ketamine Does Not Exert Protective Properties on Dopaminergic Neurons in the Lactacystin Mouse Model of Parkinson’s Disease
por: Deneyer, Lauren, et al.
Publicado: (2018)

The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease
por: Mohammad Shehata, Islam, et al.
Publicado: (2022)

Plasticity of callosal neurons in the contralesional cortex following traumatic brain injury
por: Chovsepian, Alexandra, et al.
Publicado: (2022)

Ketamine, a trauma analgesic with sex-specific immunomodulatory function
por: Spencer, Haley F., et al.
Publicado: (2022)

Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
por: Kowalczyk, Mateusz, et al.
Publicado: (2021)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Brain structural plasticity with spaceflight
por: Koppelmans, Vincent, et al.
Publicado: (2016)

A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
por: Pulcu, Erdem, et al.
Publicado: (2021)

O7.1. MIDBRAIN DOPAMINE NEURON ACTIVITY CONTROLS THE EFFECTS OF REPEATED KETAMINE ON STRIATAL DOPAMINERGIC FUNCTION
por: Kokkinou, Michelle, et al.
Publicado: (2018)

The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system
por: Kramer, Edgar R.
Publicado: (2015)

Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
por: Nekrasov, Pavel V., et al.
Publicado: (2018)

Brain angiotensin II in dopaminergic imbalance-derived pathologies: neuroinflammation and vascular responses
por: Occhieppo, Victoria Belén, et al.
Publicado: (2020)

The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs
por: Habtemariam, Solomon
Publicado: (2018)

Relevance and therapeutic potential of CypA targeting to block apoptosis inducing factor-mediated neuronal cell death
por: Doti, Nunzianna, et al.
Publicado: (2017)

Cell genesis and dendritic plasticity: a neuroplastic pas de deux in the onset and remission from depression
por: Mateus-Pinheiro, A, et al.
Publicado: (2013)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vns7ftrn1d65v6inir9oitvtvv